Mr Robert Rhoad > Dechert LLP > Philadelphia, United States > Lawyer Profile
Dechert LLP Offices
CIRCA CENTRE, 2929 ARCH STREET
PHILADELPHIA, PA 19104-2808
PENNSYLVANIA
United States
- Firm Profile
- Go to...
Mr Robert Rhoad
Work Department
Intellectual Property
Position
Partner
Career
Robert D. Rhoad represents clients in intellectual property and complex commercial litigation, primarily involving patents and licensing disputes, but also involving trade secrets, unfair competition claims, and covenants not to compete. He handles cases involving a wide range of technology areas, including cases involving patent portfolios and other proprietary information relating to drug delivery systems, pharmaceutical products, medical devices, and computer hardware and software technologies.
Mr. Rhoad has handled litigation and provided strategic patent advice for a diverse group of clients, including Endo Pharmaceuticals, Boston Scientific, Cardinal Health, Acer, Gateway, Hitachi, Pfizer, and other prominent life sciences and technology companies. He has handled many Markman hearings and trials, and has extensive experience litigating Hatch-Waxman Act ANDA infringement actions on behalf of branded pharmaceutical companies. Mr. Rhoad has tried cases in both state and federal court and has also successfully represented clients in arbitration, mediation, and other alternative dispute resolution proceedings.
Memberships
- New Jersey Intellectual Property Law Association
- New Jersey and Mercer County Bar Associations
Education
- The College of William & Mary, B.S., Computer Science, 1987, with honors, Phi Beta Kappa
- Harvard Law School, J.D., 1990, magna cum laude
Top Tier Firm Rankings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Antitrust > Civil litigation/class actions: defense
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
- Finance > Structured finance: securitization
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- International trade and national security > Customs, export controls and economic sanctions
- Dispute resolution > International arbitration
- Tax > International tax
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Investment fund formation and management > Alternative/hedge funds
- Dispute resolution > Financial services litigation